Experimental Section 1.1 General information
All chemicals and solvents were commercially available and were used without further purification. 2,6-dichloropurine, 1-bromopropane, indole, 4-formylphenylboronic acid, 4-cyanophenylboronicacid and (4-(Trifluoromethyl)phenyl)boronic acid were purchased from Innochem. 1 H NMR, 13 C NMR spectra were measured on a Bruker AM400 NMR spectrometer. Proton Chemical shifts of NMR spectra were given in ppm relative to internals reference TMS (1H, 0.00 ppm). ESI-HRMS spectral data were recorded on a Finnigan LCQDECA mass spectrometer. Fluorescence emission spectra were obtained using Hitachi F-7000 spectrometer at 298 K. Absorption spectra were recorded on a Hitachi PharmaSpec UV-1900 UV-Visible Spectrophotometer. The absolute fluorescence quantum yield was measured using a Hamamatsu quantum yield spectrometer C11347 Quantaurus_QY. The fluorescence lifetime was measured using a Hamamatsu Compact Fluorescence Lifetime Spectrometer C11367. Single crystal were grown from petroleum ether/dichloroform via solute solution diffusion method. Single crystal X-ray diffraction intensity data were collected on Agilent Technologies (Gemini). The ground-state geometries were optimized using the density function theory (DFT) method with B3LYP hybrid functional at the basis set level of 6-31G (d, p) . All the calculations were performed using Gaussian 09 package. MTS method was used for testing the cell viability and described in the experimental section. HeLa cells were obtained from Shanghai Institute of Biochemistry and Cell Biochemistry and Cell Biology, Chinese Academy of Science. Confocal lasing scanning microscopic (CLSM) images of single-photo were obtained using LSM 780 (Zeiss). Unless otherwise noted, materials were obtained from commercial suppliers and were used without further purification. All the solvents were dried according to the standard methods prior to use. All of the solvents were either HPLC or spectroscopic grade in the optical spectroscopic studies. 
Reaction procedures

AIP-CN2
2,6-dichloro-9-propyl-9H-purine (2)
S3
A mixture of 2,6-dichloropurine 1 (1.0 mmol), 1-bromopropane (1.5 mmol), and potassium carbonate (3.0 mmol) in DMSO (5 mL) was stirred for 6 h, then the mixture was filtered and evaporated under vacuum. The products were separated by flash chromatography on silica gel eluting with EtOAc/DCM (2:3) as white solid in 61% yield. 1 H NMR (400 MHz, CDCl 3 ): δ (TMS, ppm) 8.10 (s, 1H), 4.19 (t, J = 7.2 Hz, 2H), 1.90 (q, J = 7.3 Hz, 2H), 0.91 (t, J = 7.4 Hz, 3H).
2-chloro-6-(1H-indol-1-yl)-9-propyl-9H-purine (3) Under nitrogen, indole (1g, 14 mmol) was added to a suspension of NaH (2 g, 21 mmol, 60% dispersion in mineral oil) in dry THF (500 mL) at 0 °C with stirring. The resulting solution was stirred at 0 °C for 1 h, and then compound 2 (3.2 mL, 14 mmol, resolved in 50 mL dry THF) was slowly added. The mixture was allowed to warm to room temperature and stirred overnight. Water was added to quench the reaction. The organic layer was separated, and the aqueous layer was extracted with ethyl acetate (30 mL × 3). The combined organic extracts were washed with brine, and dried over Na 2 SO 4 . After removal of the solvent, the residue was purified by column chromatography on silica gel. Elution with hexane/ethyl acetate (3:1) gave compound 3 as a white solid in 57% yield. 6-(1H-indol-1-yl)-2-phenyl-9-propyl-9H-purine (AIP) Compound 3 (342 mg, 1.1 mmol), phenylboronic acid (1.5 eq), Pd(PPh 3 ) 4 (0.05eq) and 2.0 mL Na 2 CO 3 solution (2M) in 10.0 mL 2,6-dioxane was refluxed for 8 hrs under N 2 , After the reaction was completed based on the TLC, poured the reaction mixture into water and extracted with DCM. The organic layer was washed with brine, water and dried over anhydrous Na 2 SO 4 . The crude product was purified by column chromatography on silica gel. Elution with DCM gave AIP as a white solid in 89% 145.89, 138.09, 135.65, 130.86, 130.60, 129.27, 128.95, 128.26, 124.33, 123.17, 121.46, 121.00, 116.73, 108.45, 45.42, 23.03, 11.50 28, 153.90, 149.01, 146.29, 141.81, 135.61, 130.62, 128.88, 126.24, 126.20, 124.42, 123.25, 121.46, 121.42, 116.74, 108.64, 45.48, 22.99, 11.47 72, 153.60, 149.68, 143.32, 142.37, 135.84, 132.35, 130.76, 128.78, 128.64, 123.90, 122.90, 121.74, 121.00, 118.92, 116.50, 113.32, 108.52, 45.70, 23.31, 11.31 . HRMS ( 38, 156.59, 153.98, 149.03, 146.43, 143.29, 137.58, 135.63, 130.63, 130.45, 128.92, 128.83, 124.48, 123.28, 121.51, 121.45, 116.74, 108.68, 45.51, 23.03, 11.49 2-(4-(6-(1H-indol-1-yl)-9-propyl-9H-purin-2-yl)benzylidene)malononitrile (AIP-CN2) After AIP-CHO (381 mg, 1 mmol) and malononitrile (110 mg, 1.3 mmol) was added in DMF (5 mL), the piperidine (0.05 mL) was dropped to the stirred solution. Then the mixture was heated at reflux for about 2 h. After the reaction was completed based on the TLC, poured the reaction mixture into water and extracted with DCM. The organic layer was washed with brine, water and dried over anhydrous Na 2 SO 4 . The crude product was purified by column chromatography on silica gel. Elution with DCM gave AIP-CN2 as a yellow solid in 90% yield 149. 67, 143.90, 143.44, 135.83, 131.97, 131.03, 130.75, 129.20, 128.65, 124.01, 122.96, 121.84, 121.02, 116.54, 113.81, 112.70, 108.58, 82.80, 45.74, 23.32, 11.32 
Cell culture
Hela cells were cultured in Dulbecco's modified Eagle medium (DMEM) containing 10% fetal bovine serum and 1% Antibiotic-antimycotic at 37℃ in a 5% CO 2 /95% air incubator. For fluorescence imaging, cells (4 × 10 3 /well) were passed on a 6-well plate and incubated for 24 h.
Cytotoxicity study
Toxicity toward HeLa cells was determined by MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) reduction assay following literature procedures. About 10000 cells per well were seeded in 96-well plates and cultured overnight for 70-80% cell confluence. The medium was replaced with 100 μL of fresh medium with different concentration of probes, to which 100 μL complexes at 200 μL. 24 hours later, 100 μL of 20% MTT solution in PBS was replaced with the old medium in each well for additional 0.5h incubation. The metabolic activity of the probes treated cells was expressed as a relative to untreated cell controls taken as 100% metabolic activity.
Cell imaging
HeLa cells were grown on a cover slip overnight in a 35-mm petri dish. The cells were stained with certain dye at certain concentration for certain time (by adding 2 μL of stock solution in DMSO to a 2 mL of culture medium with DMSO < 0.1 vol %). The cells were imaged under a fluorescent microscope (upright BX41 Microscope) using proper excitation and emission filters for each dye: for probes, λ ex = 405 nm, λ em = 420-480 nm; for BODIPY 493/503, λ ex = 488 nm, λ em = 530-560 nm. AIP-CHO 
Molar Extinction Coefficient of all compounds
τ 1 =3.78×10 -9 (19%) τ 2 =6.21×10 -10 (71%) τ 3 =2.98×10 -8 (10%) τ avg =4.14×10 -9 τ 1 =6.03×10 -9 (47%) τ 2 =1.92×10 -8 (40%) τ 3 =1.56×10 -10 (13%) τ avg =1.05×10 -8 τ 1 =2.45×10 -2 (58%) τ 2 =2.74×10 -3 (42%) τ avg =1.53×10 -2 AIP-CN2 τ 1 =2.81×10 -9 (27%) τ 2 =3.13×10 -10 (59%) τ 3 =1.11×10 -8 (14%) τ avg =2.50×10 -9 τ 1 =2.70×10 -9 (8%) τ 2 =1.12×10 -8 (11%) τ 3 =4.86×10 -11 (81%) τ avg =3.78×10 -9 τ 1 =1.06×10 -2 (41%) τ 2 =2.00×10 -3 (59%) τ avg =5.53×10 -3 AIP-Py τ 1 =3.35×10 -9 (48%) τ 2 =5.92×10 -10 (33%) τ 3 =1.22×10 -8 (19%) τ avg =4.12×10 -9 τ 1 =4.54×10 -9 (40%) τ 2 =9.58×10 -10 (18%) τ 3 =1.26×10 -8 (42%) τ avg =7.28×10 -9 τ 1 =1.43×10 -1 (42%) τ 2 =1.29×10 -2 (58%) τ avg =6.76×10 -2
Fig. S7
The ratio of the quantum yields for the solid and solution states of all the compounds. Table S6 . The rate constants for radiative (k r ) and nonradiative decay (k nr ) were calculated from the Φ and τ values according to the formulae k r = Φ F /τ and k nr = (1-Φ F )/τ. with argon/oxygen in PBS solution. 
Theoretical Calculation of all compounds
